Dr. Bilal Ansari, MD

Dr. Ansari practices at Michiana Hematology-Oncology P C in Mishawaka, Indiana.

Dr. Ansari's NPI, 1386648749, was assigned on June 13, 2005. Dr. Ansari holds Indiana license 01051238A.

Dr. Ansari's primary practice is Michiana Hematology-Oncology P C, at 5340 Holy Cross Pkwy, Mishawaka, IN 46545 in St Joseph County. The practice phone is (574) 237-1328.

Dr. Ansari's primary practice is Michiana Hematology-Oncology P C in Mishawaka, Indiana. Dr. Ansari is also affiliated with Saint Joseph Mishawaka Medical Center. The medical group on file is Michiana Hematology-Oncology, PC. Dmand AI also links Dr. Ansari to 4 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ansari practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Ansari's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Ansari's licenses on file in 2 states: Indiana and Michigan.

CMS data shows 75,503 Medicare services from Dr. Ansari across 48 procedure codes in 2024, for 1,357 Medicare patients. Medicare paid $802,119 for them.

CMS counts 1,357 Medicare patients who saw Dr. Ansari in 2024. The largest group is 65 to 74, with 620 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ansari's median patient age at 71, with 64% women.

In 2024, Dr. Ansari wrote 4,555 Medicare Part D claims for 751 patients. 71% of them were for generic drugs. CMS names the drug for 4,039 of them, across 78 drugs with 11 or more claims each, at $10,174,615 in total drug cost. In 2023, CMS named 3,447 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Ansari for performance year 2024, reported as part of a group. Dr. Ansari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Ansari, published from 2013 to 2020. 2018 was the busiest year, with 4. The most frequent topics are Stroke Volume, Heart Failure and Magnetic Resonance Imaging, Cine. Dr. Ansari's most frequent co-authors are Julio Alonso Chirinos, MD, Scott Akers, MD and Arpita Suri, MD.

CMS Open Payments shows 170 general payments to Dr. Ansari from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,511.